Background: Underweight, overweight, and linear growth during and after cancer treatment can impact treatment efficacy and survival in childhood cancer patients, and long-term health in childhood cancer survivors (CCS). However, scientific evidence on the weight status and growth of CCS is limited. Previous studies have been small, focused on specific cancer types, or lacked objectively measured longitudinal data.
Growth trajectories and risk of underweight and overweight in childhood cancer patients and survivors: a longitudinal multicentre cohort study protocol
calendar_today
October 2, 2026
person
Calvello, A. S., Annicchiarico, L., Shoman, Y., Leuenberger, L. M., Bento, M. J., Bielicki, J., Boettcher, C., Brazzola, P., Breia, P., Caldas, G., Drexler, B., Drozdov, D., Diezi, M., Jazbec, J., Joerger, M., Konrad, D., Kuehni, C. E., Lourenco, A., Saner, C., Scheinemann, K., Schilling, F., Stefanovic, M., Taveira Gomes, T., von Bueren, A. O., Waespe, N., Wicki, A., Schindera, C., Belle, F. N., Growth consortium
domain
medrxiv